Late Breaking Abstract - Durable clinical benefit of benralizumab following oral corticosteroid reduction: The PONENTE study
A. Menzies-Gow (London, United Kingdom), M. Gurnell (Cambridge, United Kingdom), L. Heaney (Belfast, United Kingdom), J. Corren (Los Angeles, United States of America), E. Bel (Amsterdam, Netherlands), J. Maspero (Buenos Aires, Argentina), T. Harrison (Nottingham, United Kingdom), D. Jackson (London, United Kingdom), D. Price (Singapore, Singapore), N. Lugogo (Ann Arbor, United States of America), J. Kreindler (Wilmington, United States of America), A. Burden (Cambridge, United Kingdom), A. De Giorgio-Miller (Luton, United Kingdom), K. Padilla (Durham, United States of America), U. Martin (Gaithersburg, United States of America), E. Garcia Gil (Barcelona, Spain)
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Menzies-Gow (London, United Kingdom), M. Gurnell (Cambridge, United Kingdom), L. Heaney (Belfast, United Kingdom), J. Corren (Los Angeles, United States of America), E. Bel (Amsterdam, Netherlands), J. Maspero (Buenos Aires, Argentina), T. Harrison (Nottingham, United Kingdom), D. Jackson (London, United Kingdom), D. Price (Singapore, Singapore), N. Lugogo (Ann Arbor, United States of America), J. Kreindler (Wilmington, United States of America), A. Burden (Cambridge, United Kingdom), A. De Giorgio-Miller (Luton, United Kingdom), K. Padilla (Durham, United States of America), U. Martin (Gaithersburg, United States of America), E. Garcia Gil (Barcelona, Spain). Late Breaking Abstract - Durable clinical benefit of benralizumab following oral corticosteroid reduction: The PONENTE study. 1112
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: